1. Home/
  2. Compounds/
  3. selumetinib:piperlongumine (8:1 mol/mol)

selumetinib:piperlongumine (8:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2selumetinib:piperlongumine (8:1 mol/mol)
PharmacoGx selumetinib:piperlongumine (8:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to selumetinib:piperlongumine (8:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA CDK5RAP1 CTRPv2 pan-cancer AAC -0.087 0.01
mRNA MT-CO1 CTRPv2 pan-cancer AAC 0.099 0.01
mRNA OXTR CTRPv2 pan-cancer AAC -0.089 0.01
mRNA POU2AF1 CTRPv2 pan-cancer AAC -0.098 0.01
mRNA CCDC68 CTRPv2 pan-cancer AAC 0.092 0.01
mRNA DFFA CTRPv2 pan-cancer AAC -0.089 0.01
mRNA CIZ1 CTRPv2 pan-cancer AAC -0.089 0.01
mRNA RBM7 CTRPv2 pan-cancer AAC -0.09 0.01
mRNA SLC5A6 CTRPv2 pan-cancer AAC 0.093 0.01
mRNA PRDX1 CTRPv2 pan-cancer AAC -0.09 0.01
Download CSV